OPTIMIZATION OF BIOLOGIC TAPERING USING ULTRASOUND IN RA PATIENTS

被引:1
|
作者
Bawa, S. [1 ]
Todd, M. [1 ]
France, J. [1 ]
机构
[1] Gartnavel Royal Hosp, Dept Rheumatol, Glasgow, Lanark, Scotland
关键词
D O I
10.1136/annrheumdis-2018-eular.5199
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
SAT0203
引用
收藏
页码:962 / 962
页数:1
相关论文
共 50 条
  • [41] Significance of diagnostic ultrasound and MRI in patients with RA
    Weiler, V
    Stiskal, M
    Sommer, O
    Czembirek, H
    Smolen, JS
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 205 - +
  • [42] Biologic tapering for patients with psoriasis with low disease activity: data from the French PsoBioTeq Registry
    Aubert, Helene
    Arlegui, Hugo
    De Rycke, Yann
    Bachelez, Herve
    Beylot-Barry, Marie
    Dupuy, Alain
    Joly, Pascal
    Jullien, Denis
    Mahe, Emmanuel
    Paul, Carle
    Richard, Marie-Aleth
    Sbidian, Emilie
    Viguier, Manuelle
    Chosidow, Olivier
    Tubach, Florence
    Beneton, Nathalie
    BRITISH JOURNAL OF DERMATOLOGY, 2023, 188 (01) : 150 - 152
  • [43] Predictors of Initiating Biologic Monotherapy in Biologic Naive Patients with Rheumatoid Arthritis (RA) in a US Registry Population
    Pappas, Dimitrios A.
    Reed, George W.
    John, Ani
    Shewade, Ashwini
    Saunders, Katherine C.
    Devenport, Jenny
    Greenberg, Jeffrey D.
    Kremer, Joel M.
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S214 - S215
  • [44] Dose tapering of biologic agents in patients with rheumatoid arthritis—results from a cohort study in Germany
    Dietmar Krause
    Carolin Krause
    Henrik Rudolf
    Xenofon Baraliakos
    Jürgen Braun
    Elmar Schmitz
    Clinical Rheumatology, 2021, 40 : 887 - 893
  • [45] PERSISTENCE RATE WITH SUBCUTANEOUS BIOLOGIC THERAPIES IN PATIENTS WITH RHEUMATOID ARTHRITIS (RA)
    Lyu, R.
    Ding, Q.
    Govoni, M.
    Fan, T.
    VALUE IN HEALTH, 2014, 17 (07) : A384 - A384
  • [46] SAFETY OF SUBSEQUENT BIOLOGIC THERAPY IN RA PATIENTS WHO DISCONTINUED RITUXIMAB
    Genovese, Mark C.
    Breedveld, Ferdinand C.
    Emery, Paul
    Cohen, Stanley B.
    Keystone, Edward
    Matteson, Eric L.
    Burke, Laura
    Chai, Akiko
    Reiss, William
    Sweetser, Marianne
    Shaw, Tim
    RHEUMATOLOGY, 2011, 50 : 126 - 126
  • [47] Switching of biologics in RA patients who do not respond to the first biologic
    Durez, Patrick
    JOINT BONE SPINE, 2018, 85 (04) : 395 - 397
  • [48] BIOLOGIC MONOTHERAPY: A TREATMENT OPTION FOR ELDERLY RA PATIENTS WITH MULTIMORBID CONDITIONS
    Richter, A.
    Listing, J.
    Kekow, J.
    Balzer, S.
    Remstedt, S.
    Zink, A.
    Strangfeld, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 491 - 491
  • [49] Safety of other biologic therapies following rituximab treatment in RA patients
    Genovese, M.
    Breedveld, F.
    Emery, P.
    Cohen, S.
    Keystone, E.
    Matteson, E.
    Baptiste, Y.
    Burke, L.
    Reiss, W.
    Sweetser, M.
    Shaw, T.
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S785 - S785
  • [50] Outcomes in RA patients not meeting severity criteria for biologic prescription.
    Wolfe, Frederick
    Michaud, Kaleb
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S183 - S183